Microbio presented two posters at the 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), which took place in Lisbon, Portugal from April 23-26 2022. The conference provided CEO Paul Carboon and European Regional Manager Dr Raffaella Giardino the opportunity to present Microbio’s bloodstream infection test to delegates interested in improving the management of… Continue reading Microbio presents posters at ECCMID 2022
Tag: sepsis
Independent assessment of Microbio bloodstream infection test expected to be completed in May
Queensland biotechnology company Microbio expects clinical evaluation trials of its InfectID-BSI tests to be completed next month, prior to launching in the European market. US based Landrich Group is managing the trials at four locations in the USA, South America, India and Australia, undertaking a performance evaluation of Microbio InfectID assays. Read more in the… Continue reading Independent assessment of Microbio bloodstream infection test expected to be completed in May
Microbio announces capital raise to launch revolutionary bloodstream infection test in Europe
Microbio is pleased to announce that following positive domestic pilot study results, its market entry plans for its flagship InfectID-BSI test, which has the potential for significant improvement in detecting bloodstream infection and sepsis, the world’s biggest killer. Bloodstream infection (BSI) and sepsis result in 11 million deaths annually, killing more people than all forms… Continue reading Microbio announces capital raise to launch revolutionary bloodstream infection test in Europe
Introducing Microbio’s new consultant – Dr Raffaella Giardino
Microbio’s new consultant Dr Raffaella Giardino has extensive experience in highly regulated markets such as in vitro diagnostics (IVD), medical devices, and pharmaceuticals, as well as new market development, operations, finance, sales, and marketing. In her role as a remote consultant, Raffaella will support Microbio as it moves into Europe with the Blood Stream Infection… Continue reading Introducing Microbio’s new consultant – Dr Raffaella Giardino
Microbio moves toward sovereign manufacturing of diagnostic tests
Microbio has moved into new laboratories at Brisbane’s Translational Research Institute (TRI) with the aim of eventually setting up domestic manufacturing capability. More information can be found in the media release:211019_Microbio_moves_toward_sovereign_manufacturing_of_diagnostic_tests